We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App





Benchtop Chemistry Analyzer to Be Demonstrated at AACC Annual Meeting

By LabMedica International staff writers
Posted on 02 Aug 2016
Print article
Image: The EasyRA benchtop chemistry analyzer (Photo courtesy of Medica).
Image: The EasyRA benchtop chemistry analyzer (Photo courtesy of Medica).
A fully automated, compact benchtop chemistry analyzer that meets the diverse needs of small to medium sized laboratories will be on display at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).

The Medica Corporation (Bedford, MA, USA) EasyRA instrument will be on display in the expo's Booth 141. The clinical chemistry analyzer has been upgraded to enhance workflow efficiency by 50% or more. EasyRA's "smart" reagent wedges automate inventory management and are liquid, stable, and ready to use. The intuitive touch screen user interface, unsurpassed reliability, and modular design for easy maintenance make EasyRA the optimum choice for most laboratories.

Medica uses its proprietary knowledge of ion-selective electrodes and analytical microchemistry to manufacture a line of easy-to-use, easy-to-maintain, low-cost blood testing analyzers. Medica's products are designed for the small to medium-sized in-vitro diagnostic laboratory market.

Related Links:
AACC Annual Meeting & Clinical Lab Expo
Medica Corporation
Gold Supplier
Chromogenic Medium
CHROMagar Candida Plus
New
Silver Supplier
Receptor Destroying Enzyme
RDE II (Receptor Destroying Enzyme)
New
Silver Supplier
Helicobacter Pylori Test
AB HP UREASE TEST
New
Automated R-AST Solution
Radian BC

Print article

Channels

Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more

Hematology

view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more

Industry

view channel
Image: QIAGEN has acquired a majority stake in enzymes provider BLIRT S.A. (Photo courtesy of QIAGEN)

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.